LoginSignup
AbbVie logo

AbbVie

Stock
Stock
ISIN: US00287Y1091
Ticker: ABBV
US00287Y1091
ABBV

Price

Price

Historical dividends and forecast

All dividend data

AbbVie has so far distributed $6.20 in 2024. The next dividend will be paid on 14.02.2025

$3.997

CHART BY

Frequently asked questions

What is AbbVie's market capitalization?

The market capitalization of AbbVie is $310.27B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is AbbVie's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for AbbVie is 61.23. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for AbbVie?

AbbVie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.867. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for AbbVie's stock?

Currently, 31 analysts cover AbbVie's stock, with a consensus target price of $204.08. Analyst ratings provide insights into the stock's expected performance.

What is AbbVie's revenue over the trailing twelve months?

Over the trailing twelve months, AbbVie reported a revenue of $55.53B.

Is AbbVie paying dividends?

Yes, AbbVie is paying dividends. The next payment is scheduled for 14.02.2025, with an expected amount of .

What is the EBITDA for AbbVie?

AbbVie's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $25.33B. EBITDA measures the company's overall financial performance.

What is the free cash flow of AbbVie?

AbbVie has a free cash flow of $15.59B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does AbbVie have, and what sector and industry does it belong to?

AbbVie employs approximately 50,000 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of AbbVie's shares?

The free float of AbbVie is 1.77B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$310.27B
EPS (TTM) 
$2.867
Free Float 
1.77B
P/E ratio (TTM) 
61.23
Revenue (TTM) 
$55.53B
EBITDA (TTM) 
$25.33B
Free Cashflow (TTM) 
$15.59B

Pricing

1D span
$170.86$176.94
52W span
$153.60$207.18

Analyst Ratings

The price target is $204.08 and the stock is covered by 31 analysts.

Buy

19

Hold

12

Sell

0

Information

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Employees
50,000
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
US00287Y1091
Primary Ticker
ABBV

Knockouts

Join the conversation
Sign upLogin